Improved control of bulky prostate carcinoma with sequential estrogen and radiation therapy
Journal Article
·
· Int. J. Radiat. Oncol., Biol. Phys.; (United States)
Patients with bulky prostate cancer have usually been treated by palliative measures because the likelihood of tumor control with definitive irradiation has been low and the development of distant metastases high. The addition of estrogen to irradiation has not been shown to be of value. However, the method of estrogen administration may have been the cause for the apparent lack of benefit. In this study estrogen was used for two months prior to and concurrent with irradiation. Between 1975 and 1980, 25 patients with bulky prostate cancer received sequential estrogen and irradiation, 12 patients irradiation alone and six patients irradiation after having become refractory to long-term estrogen use. Eighteen of 25 (72%) treated by sequential estrogen and irradiation, 14/17 (82%) with estrogen responsive cancer and 4/8 (50%) with estrogen resistant cancer had a complete tumor response. Six of 11 (55%) patients treated by irradiation alone and 2/6 (33%) treated by irradiation for estrogen refractory cancer had a complete tumor response. Distant metastases was observed in 15% of patients when the primary tumor was controlled and 30% when there was persistent or recurrent local disease. The results with the use of estrogen prior to and concurrent with irradiation is encouraging. Estrogen may shrink the cancer and allow for a more favorable geometry for external irradiation.
- Research Organization:
- Univ. of Southern California Medical Center, Los Angeles
- OSTI ID:
- 6578741
- Journal Information:
- Int. J. Radiat. Oncol., Biol. Phys.; (United States), Journal Name: Int. J. Radiat. Oncol., Biol. Phys.; (United States) Vol. 10:7; ISSN IOBPD
- Country of Publication:
- United States
- Language:
- English
Similar Records
Radiation therapy in adenocarcinoma of the prostate with pelvic lymph node involvement on lymphadenectomy
125-iodine reimplantation for locally progressive prostatic carcinoma
Disease-related effects of perioperative blood transfusions associated with sup 125 I seed implantation for prostate carcinoma
Journal Article
·
Thu Jan 31 23:00:00 EST 1980
· Int. J. Radiat. Oncol., Biol. Phys.; (United States)
·
OSTI ID:6866050
125-iodine reimplantation for locally progressive prostatic carcinoma
Journal Article
·
Sat Sep 01 00:00:00 EDT 1990
· Journal of Urology; (USA)
·
OSTI ID:6526160
Disease-related effects of perioperative blood transfusions associated with sup 125 I seed implantation for prostate carcinoma
Journal Article
·
Wed Aug 01 00:00:00 EDT 1990
· Urology (Ridgewood, N.J.); (USA)
·
OSTI ID:6791363
Related Subjects
550603 -- Medicine-- External Radiation in Therapy-- (1980-)
560151* -- Radiation Effects on Animals-- Man
62 RADIOLOGY AND NUCLEAR MEDICINE
63 RADIATION, THERMAL, AND OTHER ENVIRON. POLLUTANT EFFECTS ON LIVING ORGS. AND BIOL. MAT.
ACID PHOSPHATASE
BIOLOGICAL EFFECTS
BIOLOGICAL RADIATION EFFECTS
BODY
CARCINOMAS
DIARRHEA
DIGESTIVE SYSTEM
DISEASES
EDEMA
ENZYMES
ESTERASES
ESTROGENS
GASTROINTESTINAL TRACT
GLANDS
HORMONES
HYDROLASES
INTESTINES
LARGE INTESTINE
LYMPH NODES
LYMPHATIC SYSTEM
MALE GENITALS
MEDICINE
NEOPLASMS
NUCLEAR MEDICINE
ORGANS
PATHOLOGICAL CHANGES
PATIENTS
PHOSPHATASES
PROSTATE
RADIATION EFFECTS
RADIOINDUCTION
RADIOLOGY
RADIOSENSITIVITY EFFECTS
RADIOTHERAPY
SIDE EFFECTS
STEROID HORMONES
SYMPTOMS
THERAPY
560151* -- Radiation Effects on Animals-- Man
62 RADIOLOGY AND NUCLEAR MEDICINE
63 RADIATION, THERMAL, AND OTHER ENVIRON. POLLUTANT EFFECTS ON LIVING ORGS. AND BIOL. MAT.
ACID PHOSPHATASE
BIOLOGICAL EFFECTS
BIOLOGICAL RADIATION EFFECTS
BODY
CARCINOMAS
DIARRHEA
DIGESTIVE SYSTEM
DISEASES
EDEMA
ENZYMES
ESTERASES
ESTROGENS
GASTROINTESTINAL TRACT
GLANDS
HORMONES
HYDROLASES
INTESTINES
LARGE INTESTINE
LYMPH NODES
LYMPHATIC SYSTEM
MALE GENITALS
MEDICINE
NEOPLASMS
NUCLEAR MEDICINE
ORGANS
PATHOLOGICAL CHANGES
PATIENTS
PHOSPHATASES
PROSTATE
RADIATION EFFECTS
RADIOINDUCTION
RADIOLOGY
RADIOSENSITIVITY EFFECTS
RADIOTHERAPY
SIDE EFFECTS
STEROID HORMONES
SYMPTOMS
THERAPY